Answers are grounded in this paper and cite their sources.
Quasi-experimental study shows improved nursing practices in intravenous chemotherapy, indicating better patient safety efforts.
Background: Intravenous chemotherapy administration is a procedure with considerable risk, inherently associated with the potential for substantial medication errors. Nurses play a pivotal role in this procedure, and having sufficient knowledge and practice is vital for ensuring patient safety. Objective: To evaluate the impact of clinical pharmacists' educational interventions regarding intravenous chemotherapy administration practice. Methods: A quasi-experimental, pre-post-test study was conducted at Kirkuk Oncology and Hematology Center and Oncology Teaching Hospital in Baghdad. A convenience sample of 50 nurses responsible for intravenous chemotherapy administration participated. The intervention consisted of educational sessions by a clinical pharmacist, covering essential aspects of safe intravenous chemotherapy administration. The baseline knowledge evaluation was done using a self-administered questionnaire, followed by the educational intervention, and then the practice evaluation phase. Results: Before chemotherapy, nurses failed to follow the recommended practices in 79% of observed instances (2,605 out of 3,300). This indicates a significant lack of adherence to the 22 pre-chemotherapy checklist items. Conversely, nurses were highly compliant with procedures during chemotherapy administration, with only 10.67% failing to follow proper protocol. After chemotherapy, the rate of non-compliance was extremely high. Nurses did not follow the proper procedures in most observed opportunities, with a non-compliance rate of 99.89%. This trend was observed across the 12 post-chemotherapy practice items. There was no significant association between nurse characteristics and practices after the administration of chemotherapy. Conclusions: Clinical pharmacists' educational interventions can enhance nurses' knowledge and practice in administering intravenous chemotherapy.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: